Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

about

TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes Strategies for local gene therapy of corneal allograft rejection.

P2860

Q36939054-92081195-1569-4927-886A-8F4F1B20FE78 Q38098508-538F420A-94F5-47CC-A6A6-98755718B731

P2860

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

Item

http://www.wikidata.org/entity/Q57219256

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2010

@uk

name

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@en

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@nl

type

Item

label

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@en

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@nl

prefLabel

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@en

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@nl

P1476

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

@en

P2093

Bing Wang

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

Corneal neovascularization. Pathogenesis and inhibition

Gene Transfer Technology in Therapy: Current Applications and Future Goals.

VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth.

Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor.

Progress in the use of adeno-associated viral vectors for gene therapy.

Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.

P304

295-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3980/J.ISSN.2222-3959.2010.04.04

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22553577

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3340739

http://www.w3.org/2001/XMLSchema#string

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

about

P2860

P2860

Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932